These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32007543)

  • 1. Prolonged Wireless pH Monitoring in Patients With Persistent Reflux Symptoms Despite Proton Pump Inhibitor Therapy.
    Hasak S; Yadlapati R; Altayar O; Sweis R; Tucker E; Knowles K; Fox M; Pandolfino J; Gyawali CP
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2912-2919. PubMed ID: 32007543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring.
    Rengarajan A; Savarino E; Della Coletta M; Ghisa M; Patel A; Gyawali CP
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):589-595. PubMed ID: 31163276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial.
    Yadlapati R; Masihi M; Gyawali CP; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE
    Gastroenterology; 2021 Jan; 160(1):174-182.e1. PubMed ID: 32949568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic measurement of gastric pH associates with persistent acid reflux in patients treated with proton-pump inhibitors for gastroesophageal reflux disease.
    Januszewicz W; Hartley J; Waldock W; Roberts G; Alias B; Hobson A; Wernisch L; di Pietro M
    United European Gastroenterol J; 2019 Dec; 7(10):1389-1398. PubMed ID: 31807307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antisecretory therapy and study duration on ambulatory esophageal pH monitoring.
    Kushnir VM; Sayuk GS; Gyawali CP
    Dig Dis Sci; 2011 May; 56(5):1412-9. PubMed ID: 21046245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain.
    Kushnir VM; Sayuk GS; Gyawali CP
    Am J Gastroenterol; 2010 May; 105(5):1032-8. PubMed ID: 19920808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Wireless Reflux Monitoring Metrics to Predict Discontinuation of Proton Pump Inhibitor Therapy.
    Yadlapati R; Gyawali CP; Masihi M; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE
    Am J Gastroenterol; 2022 Oct; 117(10):1573-1582. PubMed ID: 35973148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical role of ambulatory reflux monitoring in PPI non-responders: recommendation statements.
    Yadlapati R; Gawron AJ; Gyawali CP; Chen J; Clarke J; Fass R; Jain A; Lynch K; Khan A; Katz PO; Katzka DA; Richter J; Schnoll-Sussman F; Spechler SJ; Vaezi MF; Vela M; Pandolfino JE
    Aliment Pharmacol Ther; 2022 Oct; 56(8):1274-1283. PubMed ID: 35971888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
    Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M
    Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
    Patel A; Sayuk GS; Kushnir VM; Chan WW; Gyawali CP
    Neurogastroenterol Motil; 2016 Apr; 28(4):513-21. PubMed ID: 26686239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease.
    Prakash C; Clouse RE
    Clin Gastroenterol Hepatol; 2005 Apr; 3(4):329-34. PubMed ID: 15822037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional lumen imaging probe topography identifies patients with normal acid exposure and esophageal hypervigilance amongst proton-pump inhibitor non-responders.
    Biermann M; Hersh M; Kline M; Fowler H; Calderon L; Godiers M; Kundu S; Jain AS
    Surg Endosc; 2024 Jan; 38(1):291-299. PubMed ID: 37991572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading.
    Capovilla G; Salvador R; Spadotto L; Voltarel G; Pesenti E; Perazzolo A; Nicoletti L; Merigliano S; Costantini M
    Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trajectory assessment is useful when day-to-day esophageal acid exposure varies in prolonged wireless pH monitoring.
    Yadlapati R; Ciolino JD; Craft J; Roman S; Pandolfino JE
    Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30124795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.
    Patel A; Sayuk GS; Gyawali CP
    Neurogastroenterol Motil; 2016 Sep; 28(9):1382-90. PubMed ID: 27061427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
    Lacy BE; Chehade R; Crowell MD
    Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.